Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DMN03O
|
|||
Drug Name |
IMM-124E
|
|||
Drug Type |
Antibody
|
|||
Indication | Non-alcoholic fatty liver disease [ICD-11: DB92; ICD-10: K76.0; ICD-9: 571.8] | Phase 2 | [1] | |
Company |
Immuron
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT02316717) A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.